HTML has links - PDF has Authentication

Chapter 246-881 WAC

Last Update: 12/20/95

PHARMACY—PRESCRIPTION DRUG PRICE ADVERTISING

WAC Sections

HTMLPDF246-881-010Drug price advertising defined.
HTMLPDF246-881-020Drug price advertising conditions.
HTMLPDF246-881-030Prohibition on advertising controlled substances.
HTMLPDF246-881-040Drug price disclosure—Required.


PDF246-881-010

Drug price advertising defined.

Drug price advertising is the dissemination of nonpromotional information pertaining to the prices of legend or prescription drugs.
[Statutory Authority: RCW 18.64.005 and chapter 18.64A RCW. WSR 91-18-057 (Order 191B), recodified as § 246-881-010, filed 8/30/91, effective 9/30/91; Order 124, § 360-23-010, filed 10/31/74; Order 120, § 360-23-010, filed 3/11/74.]



PDF246-881-020

Drug price advertising conditions.

A pharmacy may advertise legend or prescription drug prices provided:
(1) The advertising complies with all state and federal laws, including regulations of the United States Food and Drug Administration and the Washington State Consumer Protection Act, chapter 19.86 RCW.
(2) The advertising is solely directed towards providing consumers with drug price information and does not promote the use of a prescription drug or drugs to the public.
(3) The drug price advertising shall contain all the following information for all drug products or brand names used in the advertisement:
(a) The proprietary name of the drug product advertised, if any,
(b) The generic name of the drug product advertised, if any,
(c) The strength of the drug product advertised. If the drug product advertised contains more than one active ingredient and a relevant strength can be associated with it without indicating each active ingredient, the generic name and quantity of each active ingredient is not required.
(d) The dosage form of the drug product advertised, and
(e) The price charged for a specified quantity of the drug product.
(4) Advertising of any generic drug that in any way compares a generic drug to a brand name drug may not in any manner imply that the brand name drug is the product offered for sale.
[Statutory Authority: RCW 18.64.005 and chapter 18.64A RCW. WSR 91-18-057 (Order 191B), recodified as § 246-881-020, filed 8/30/91, effective 9/30/91. Statutory Authority: RCW 18.64.005(11). WSR 79-10-007 (Order 151, Resolution No. 9/79), § 360-23-020, filed 9/6/79; Order 124, § 360-23-020, filed 10/31/74; Order 120, § 360-23-020, filed 3/11/74.]



PDF246-881-030

Prohibition on advertising controlled substances.

No person, partnership, corporation, association or agency shall advertise controlled substances for sale to the general public in any manner that promotes or tends to promote the use or abuse of those drugs. Controlled substances shall not be physically displayed to the public.
[Statutory Authority: RCW 18.64.005 and chapter 18.64A RCW. WSR 91-18-057 (Order 191B), recodified as § 246-881-030, filed 8/30/91, effective 9/30/91; Order 124, § 360-23-030, filed 10/31/74.]



PDF246-881-040

Drug price disclosure—Required.

No pharmacy shall refuse to disclose the retail price of a prescription drug upon request by a consumer.
[Statutory Authority: RCW 18.64.005. WSR 96-02-008, § 246-881-040, filed 12/20/95, effective 1/20/96. Statutory Authority: RCW 18.64.005 and chapter 18.64A RCW. WSR 91-18-057 (Order 191B), recodified as § 246-881-040, filed 8/30/91, effective 9/30/91; Order 124, § 360-23-050, filed 10/31/74.]